Teva Pharmaceutical Industries reported $1.89B in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amarin AMRN:US USD 93.16M 23.15M
Biogen BIIB:US USD 491.5M 108.3M
Coherus Biosciences CHRS:US USD 9.92M 7.57M
Emergent Biosolutions EBS:US USD 103.5M 300K
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Henry Schein HSIC:US USD 1B 47M
Horizon Pharma HZNP:US USD 155.8M 123.69M
Lannett LCI:US USD 33.16M 9.1M
Novartis NOVN:VX USD 5.15B 453M
Pacira Pharmaceuticals PCRX:US USD 15.22M 2.29M
Patterson Companies PDCO:US USD 702.46M 12.26M
Perrigo Ordinary Shares PRGO:US USD 537.3M 75.9M
Revance Therapeutics RVNC:US USD 4.55M 3.8M
Takeda 4502:JP JPY 381.11B 7.51B
Teva Pharmaceutical Industries TEVA:US USD 1.89B 252M
Xeris Pharmaceuticals Inc XERS:US USD 3.92M 2.72M
Zoetis ZTS:US USD 405M 32M